UY30263A1 - Utilizacion de un compuesto anti-aterotrombotico para la obtencion de medicamentos destinados al tratamiento de los trastornos vasculares - Google Patents
Utilizacion de un compuesto anti-aterotrombotico para la obtencion de medicamentos destinados al tratamiento de los trastornos vascularesInfo
- Publication number
- UY30263A1 UY30263A1 UY30263A UY30263A UY30263A1 UY 30263 A1 UY30263 A1 UY 30263A1 UY 30263 A UY30263 A UY 30263A UY 30263 A UY30263 A UY 30263A UY 30263 A1 UY30263 A1 UY 30263A1
- Authority
- UY
- Uruguay
- Prior art keywords
- treatment
- obtaining
- vascular disorders
- aterotrombotic
- medicines
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente invención se refiere a la utilización de un antagonista específico de los receptores TP para la obtención de medicamentos destinados al tratamiento de los trastornos vasculares en el paciente que presenta un antecedente de accidente vascular cerebral, especialmente para la reducción de los sucesos cerebro-vasculares y cardiovasculares en los pacientes que presentan un antecedente de accidente isquémico cerebral (AIC) o de ataque isquémico transitorio (AIT).
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0603082A FR2899473B1 (fr) | 2006-04-07 | 2006-04-07 | Utilisation d'un compose anti-atherothrombotique pour l'obtention de medicaments destines au traitement des troubles vasculaires |
Publications (1)
Publication Number | Publication Date |
---|---|
UY30263A1 true UY30263A1 (es) | 2007-05-31 |
Family
ID=37084627
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY30263A UY30263A1 (es) | 2006-04-07 | 2007-04-09 | Utilizacion de un compuesto anti-aterotrombotico para la obtencion de medicamentos destinados al tratamiento de los trastornos vasculares |
Country Status (40)
Country | Link |
---|---|
US (1) | US20070238785A1 (es) |
EP (2) | EP1842537B1 (es) |
JP (1) | JP2009532447A (es) |
KR (2) | KR20070100658A (es) |
CN (2) | CN101049292A (es) |
AP (1) | AP2007003952A0 (es) |
AR (1) | AR060288A1 (es) |
AT (1) | ATE452633T1 (es) |
AU (1) | AU2007201525A1 (es) |
BR (1) | BRPI0701597A (es) |
CA (1) | CA2582394A1 (es) |
CO (1) | CO5820217A1 (es) |
CR (1) | CR9020A (es) |
CY (1) | CY1109793T1 (es) |
DE (1) | DE602007003880D1 (es) |
DK (1) | DK1842537T3 (es) |
EA (1) | EA013874B1 (es) |
ES (1) | ES2338600T3 (es) |
FR (1) | FR2899473B1 (es) |
GE (1) | GEP20094782B (es) |
GT (1) | GT200700029A (es) |
HR (1) | HRP20100091T1 (es) |
IL (1) | IL182406A0 (es) |
MA (1) | MA28988B1 (es) |
MX (1) | MX2007004108A (es) |
NI (1) | NI200700083A (es) |
NO (1) | NO20071833L (es) |
NZ (1) | NZ554348A (es) |
PE (1) | PE20071147A1 (es) |
PL (1) | PL1842537T3 (es) |
PT (1) | PT1842537E (es) |
RS (1) | RS51207B (es) |
SG (1) | SG136882A1 (es) |
SI (1) | SI1842537T1 (es) |
SV (1) | SV2008003053A (es) |
TN (1) | TNSN07117A1 (es) |
TW (1) | TW200808306A (es) |
UY (1) | UY30263A1 (es) |
WO (1) | WO2007116138A1 (es) |
ZA (1) | ZA200702866B (es) |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9102862D0 (en) * | 1991-02-11 | 1991-03-27 | Erba Carlo Spa | N-imidazolyl derivatives of substituted or alkoxymino tetrahydronaphthalenes and chromans |
RU2120292C1 (ru) * | 1992-07-22 | 1998-10-20 | Российско-германское акционерное общество закрытого типа "УТИЛЕКС" | Способ лечения мозговых сосудистых кризов |
FR2711139B1 (fr) * | 1993-10-15 | 1995-12-01 | Adir | Nouveaux dérivés de 1,2,3,4-tétrahydronaphtalène, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent. |
DE4343776A1 (de) * | 1993-12-17 | 1995-06-22 | Schering Ag | Cyclopentanonderivate, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung |
JPH08119936A (ja) * | 1994-10-18 | 1996-05-14 | Fujisawa Pharmaceut Co Ltd | 複素環式誘導体 |
FR2805261A1 (fr) * | 2000-02-18 | 2001-08-24 | Adir | Nouveaux derives d'acides 6-amino ou 6-hydrazinosulfonyl-3- quinolinyl phosphoniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
FR2857593B1 (fr) * | 2003-07-18 | 2005-10-14 | Servier Lab | Composition pharmaceutique orodispersible d'un compose antithrombotique |
FR2860436B1 (fr) * | 2003-10-03 | 2006-01-20 | Servier Lab | Nouvelle association d'un anti-atherothrombotique et d'un antiagregant plaquettaire |
-
2006
- 2006-04-07 FR FR0603082A patent/FR2899473B1/fr not_active Expired - Fee Related
-
2007
- 2007-03-26 AP AP2007003952A patent/AP2007003952A0/xx unknown
- 2007-03-26 PE PE2007000339A patent/PE20071147A1/es not_active Application Discontinuation
- 2007-03-27 CA CA002582394A patent/CA2582394A1/fr not_active Abandoned
- 2007-03-28 TN TNP2007000117A patent/TNSN07117A1/fr unknown
- 2007-03-28 GT GT200700029A patent/GT200700029A/es unknown
- 2007-03-28 CR CR9020A patent/CR9020A/es not_active Application Discontinuation
- 2007-03-29 NI NI200700083A patent/NI200700083A/es unknown
- 2007-04-03 CO CO07033656A patent/CO5820217A1/es not_active Application Discontinuation
- 2007-04-03 MA MA29799A patent/MA28988B1/fr unknown
- 2007-04-04 TW TW096112170A patent/TW200808306A/zh unknown
- 2007-04-04 AR ARP070101419A patent/AR060288A1/es unknown
- 2007-04-04 MX MX2007004108A patent/MX2007004108A/es not_active Application Discontinuation
- 2007-04-05 NZ NZ554348A patent/NZ554348A/en unknown
- 2007-04-05 ZA ZA200702866A patent/ZA200702866B/xx unknown
- 2007-04-05 GE GEAP20079967A patent/GEP20094782B/en unknown
- 2007-04-05 SG SG200702553-9A patent/SG136882A1/en unknown
- 2007-04-05 BR BRPI0701597-6A patent/BRPI0701597A/pt not_active IP Right Cessation
- 2007-04-05 US US11/784,070 patent/US20070238785A1/en not_active Abandoned
- 2007-04-05 AU AU2007201525A patent/AU2007201525A1/en not_active Abandoned
- 2007-04-06 PL PL07290421T patent/PL1842537T3/pl unknown
- 2007-04-06 JP JP2009503618A patent/JP2009532447A/ja active Pending
- 2007-04-06 EP EP07290421A patent/EP1842537B1/fr active Active
- 2007-04-06 EP EP09163685A patent/EP2105132A1/fr not_active Withdrawn
- 2007-04-06 AT AT07290421T patent/ATE452633T1/de active
- 2007-04-06 KR KR1020070034004A patent/KR20070100658A/ko active Search and Examination
- 2007-04-06 EA EA200700573A patent/EA013874B1/ru not_active IP Right Cessation
- 2007-04-06 DK DK07290421.2T patent/DK1842537T3/da active
- 2007-04-06 WO PCT/FR2007/000588 patent/WO2007116138A1/fr active Application Filing
- 2007-04-06 SI SI200730154T patent/SI1842537T1/sl unknown
- 2007-04-06 CN CNA2007100910717A patent/CN101049292A/zh active Pending
- 2007-04-06 PT PT07290421T patent/PT1842537E/pt unknown
- 2007-04-06 ES ES07290421T patent/ES2338600T3/es active Active
- 2007-04-06 RS RSP-2010/0111A patent/RS51207B/sr unknown
- 2007-04-06 DE DE602007003880T patent/DE602007003880D1/de active Active
- 2007-04-06 CN CN200910205034A patent/CN101693025A/zh active Pending
- 2007-04-09 UY UY30263A patent/UY30263A1/es not_active Application Discontinuation
- 2007-04-10 IL IL182406A patent/IL182406A0/en unknown
- 2007-04-10 NO NO20071833A patent/NO20071833L/no not_active Application Discontinuation
-
2008
- 2008-10-02 SV SV2008003053A patent/SV2008003053A/es unknown
-
2009
- 2009-07-22 KR KR1020090066778A patent/KR20090086500A/ko not_active Application Discontinuation
-
2010
- 2010-02-05 CY CY20101100118T patent/CY1109793T1/el unknown
- 2010-02-19 HR HR20100091T patent/HRP20100091T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2007003614A1 (es) | Compuestos derivados de sulfonil-fenil-2h-[1,2,4]oxadiazol-5-ona; composicion farmaceutica que comprende a dicho compuesto; procedimiento de preparacion; y uso del compuesto en el tratamiento de trastornos del metabolismo, como diabetes mellitus, dis | |
GT200800250A (es) | Arilimidazolonas y ariltriazolonas sustituidas como inhibidores de receptores de vasopresina | |
CU23874B1 (es) | 4-aril-1,4-dihidro-1,6-naftiridinamidas sustituidas y su uso | |
GT201000182A (es) | Regimen de dosificacion asociado con ésteres de paliperidona inyectables de acción prolongada | |
CY1113315T1 (el) | Ιμιδαζολοκαρβοξαμιδια | |
CL2007003262A1 (es) | Compuestos derivados de 1,4-benzotiepina-1,1-dioxido; composicion farmaceutica; y su uso para el tratamiento de trastornos del metabolismo de lipidos, hiperlipidemia, resistencia a la insulina, diabetes y trastornos del snc, entre otras enfermedades. | |
UY31314A1 (es) | Amidas heterociclicas y sus métodos de uso-976 | |
CL2008003116A1 (es) | Compuestos heterocíclicos bicíclicos; composición farmacéutica que comprende a dichos compuestos; y su uso en el tratamiento o prevención de enfermedades tales como diabetes, obesidad, trastorno metabólico, enfermedad cardiovascular entre otras. | |
CO6260015A2 (es) | Metodos y tratamiento para la dependencia, mediante la administracion de un agente psicoestimulante, un opiode y otros | |
CL2007001887A1 (es) | Compuestos derivados de bifensustuidas por tetrazol; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de enfermedades asociadas con los receptores purinergicos de p2x, tales como trastornos gastrointes | |
HN2011001280A (es) | Compuestos de arilo con sustituyentes heterociclicos y su uso | |
UY31922A (es) | Compuestos | |
DK2319517T3 (da) | Anvendelse af prodrugs til okulær, intravenøs administration | |
BR112015022465A2 (pt) | método para tratamento não-tóxico para síndrome de abstinência de drogas | |
BRPI0713447A2 (pt) | composição forma de dosagem oral sólida, e, método para o tratamento de dor | |
BR112013024973A2 (pt) | prevenção de hipoglicemia em pacientes com diabetes mellitus do tipo 2 | |
CY1119560T1 (el) | Μεθοδοι για μειωση αδηφαγικης διαταραχης ή ψυχαναγκαστικης υπερφαγιας | |
BR112018003817A2 (pt) | materiais auxiliares cirúrgicos com medicamentos afetados por ativadores | |
CL2013000709A1 (es) | Composicion que contiene nifurtimox y un antihelmintico seleccionado de: pf1022, emopdepsido, tribendimidina, amidantel, bay d 9216, praziquantel o benzoato de bencilo; util en el tratamiento de enfermedades causadas por giardias (div. sol. 1577-10). | |
UY33529A (es) | Composiciones farmacéuticas para el tratamiento de enfermedades respiratorias e inflamatorias? | |
NI200700083A (es) | Utilización de un compuesto anti-aterotrombótico para la obtención de medicamentos destinados al tratamiento de los trastornos vasculares | |
AR073086A1 (es) | Composicion farmaceutica para el tratamiento de un trastorno de ansiedad que comprende exo-7-(8-h-8-aza-biciclo(3,2,1)oct-3-iloxi)-cromen-2-ona, uso y equipo | |
BRPI0813658A2 (pt) | composto, medicamento, composição farmacêutica, preparação farmacêutica combinada, usos de um composto e de uma preparação combinada, e, processo para a preparação de composto. | |
AR048460A1 (es) | Tratamiento de la funcion respiratoria alterada con gaboxadol | |
Sacca | Marijuana/nabiximols |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
109 | Application deemed to be withdrawn |
Effective date: 20170606 |